Executive Vice President, Chief Business Officer · IONIS PHARMACEUTICALS INC (IONS)

Joseph Baroldi

FY2022 is the first fiscal year CompBrief holds for Joseph Baroldi as a named executive officer of IONIS PHARMACEUTICALS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$4,016,572

Salary $476,500Stock awards $1,776,050Bonus $257,310

2nd of 6 named executive officers at Ionis Pharmaceuticals by FY2022 total.

6 named officers on file for IONIS PHARMACEUTICALS, FY2022

Joseph Baroldi’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • IONS’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how IONIS PHARMACEUTICALS’s whole pay program stands against its peers

  • IONIS PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IONS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 20, 2023 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Joseph Baroldi’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Joseph Baroldi compensation by year

IONIS PHARMACEUTICALS Summary Compensation Table · the one fiscal year held
In US dollars, as IONIS PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022
Salary$476,500
Bonus$257,310
Stock awards$1,776,050
Option awards$1,468,020
Non-equity incentive$0
Pension and deferred compensation$0
All other$38,693
Total$4,016,572

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IONIS PHARMACEUTICALS INC DEF 14A filed April 20, 2023, accession 0001140361-23-019309, and prior-year filings. Open the filing on EDGAR.

How this page was built: the IONIS PHARMACEUTICALS INC filed document, accession 0001140361-23-019309. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2023.

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU43,350$1,637,330—
Option86,700—$31.80

Per the Outstanding Equity Awards at Fiscal Year-End table in IONIS PHARMACEUTICALS INC's FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

83 Form 4 lines since the FY2022 proxy (filed April 20, 2023)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-06-26Exercise or conversion derivative10b5-13,866$0.000
2026-06-26Sale10b5-15,635$80.164,669
2026-06-26Exercise or conversion derivative10b5-11,769$0.000
2026-06-26Exercise or conversion10b5-11,769$32.6010,304
2026-06-26Exercise or conversion10b5-13,866$56.788,535
2026-04-28Sale10b5-11,626$71.7944,909
2026-04-16Sale—5,619$74.5646,535
2026-04-15Exercise or conversion—10,837$0.0052,154

The 8 most recent of 83 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

IONIS PHARMACEUTICALS’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Brett MoniaPresident, Chief Executive Officer$7,299,077
Joseph Baroldi · this pageExecutive Vice President, Chief Business Officer$4,016,572
Elizabeth HougenExecutive Vice President, Finance and Chief Financial Officer$2,488,088
Onaiza Cadoret-ManierExecutive Vice President, Chief Global Product Strategy and Operations Officer$2,403,567
Richard GearyExecutive Vice President, Chief Development Officer$2,305,611
Eric SwayzeEVP, Research$68,951

The full IONIS PHARMACEUTICALS compensation record

free company brief

This page is one person within IONIS PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the IONIS PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are IONIS PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Joseph Baroldi's compensation dossier · One-time report. No refunds.